Lista de obras - Sankar Surendran - Dominio Público Uruguay

Adeno-associated virus-mediated aspartoacylase gene transfer to the brain of knockout mouse for canavan disease

artículo científico publicado en 2003

Altered expression of myocilin in the brain of a mouse model for phenylketonuria (PKU).

artículo científico publicado en 2005

Altered expression of neuronal nitric oxide synthase in the duodenum longitudinal muscle-myenteric plexus of obesity induced diabetes mouse: implications on enteric neurodegeneration.

artículo científico publicado en 2005

Ashwagandha leaf extract: a potential agent in treating oxidative damage and physiological abnormalities seen in a mouse model of Parkinson's disease.

artículo científico publicado en 2009

Aspartoacylase Deficiency in the White Matter of Human Immunodeficiency Virus Encephalitis: Novel Mechanism in Axonal Damage ⬇️

artículo científico publicado el 6 de septiembre de 2011

Aspartoacylase gene knockout in the mouse: impact on reproduction

artículo científico publicado en 2005

Aspartoacylase gene knockout results in severe vacuolation in the white matter and gray matter of the spinal cord in the mouse

artículo científico publicado en 2005

Biopterin responsive phenylalanine hydroxylase deficiency

artículo científico publicado en 2004

Canavan disease: a monogenic trait with complex genomic interaction.

artículo científico publicado en 2003

Correction of kinetic and stability defects by tetrahydrobiopterin in phenylketonuria patients with certain phenylalanine hydroxylase mutations

artículo científico publicado en 2004

DOOR syndrome: deficiency of E1 component of the 2-oxoglutarate dehydrogenase complex.

artículo científico publicado en 2002

Defective N-acetylaspartate catabolism reduces brain acetate levels and myelin lipid synthesis in Canavan's disease.

artículo científico publicado en 2005

Expression of calpastatin, minopontin, NIPSNAP1, rabaptin-5 and neuronatin in the phenylketonuria (PKU) mouse brain: possible role on cognitive defect seen in PKU.

artículo científico publicado en 2005

Expression of glutamate transporter, GABRA6, serine proteinase inhibitor 2 and low levels of glutamate and GABA in the brain of knock-out mouse for Canavan disease

artículo científico publicado en 2003

Fas (CD95) alters neuronal nitric oxide synthase expression to contribute in diabetic gastroparesis

artículo científico publicado en 2006

Founder mutation R245H of Sanfilippo syndrome type A in the Cayman Islands

artículo científico publicado en 2002

High level of orexin A observed in the phenylketonuria mouse brain is due to the abnormal expression of prepro-orexin.

artículo científico publicado en 2004

High levels of orexin A in the brain of the mouse model for phenylketonuria: possible role of orexin A in hyperactivity seen in children with PKU.

artículo científico publicado en 2003

Hyaluronidase increases the biodistribution of acid alpha-1,4 glucosidase in the muscle of Pompe disease mice: an approach to enhance the efficacy of enzyme replacement therapy

artículo científico publicado en 2006

Malonyl CoA decarboxylase deficiency: C to T transition in intron 2 of the MCD gene.

artículo científico publicado en 2001

Mental retardation and hypotonia seen in the knock out mouse for Canavan disease is not due to succinate semialdehyde dehydrogenase deficiency.

artículo científico publicado en 2004

Mouse neural progenitor cells differentiate into oligodendrocytes in the brain of a knockout mouse model of Canavan disease

artículo científico publicado en 2004

Mutations in the Regulatory Domain of Phenylalanine Hydroxylase and Response to Tetrahydrobiopterin

article

Parkinson's disease: oxidative stress and therapeutic approaches.

artículo científico publicado en 2010

Possible role of fas antigen (CD 95) in human amniotic epithelial cell death: an in vitro study

artículo científico publicado en 2001

Soluble factors from IL-1β-stimulated astrocytes activate NR1a/NR2B receptors: implications for HIV-1-induced neurodegeneration.

artículo científico publicado en 2010

Trends in enzyme therapy for phenylketonuria.

artículo científico publicado en 2004

Upregulation of N-acetylaspartic acid alters inflammation, transcription and contractile associated protein levels in the stomach and smooth muscle contractility.

artículo científico publicado en 2007

Upregulation of N-acetylaspartic acid induces oxidative stress to contribute in disease pathophysiology.

artículo científico publicado en 2011

Upregulation of N-acetylaspartic acid resulting nitric oxide toxicity induces aspartoacylase mutations and protein interaction to cause pathophysiology seen in Canavan disease ⬇️

artículo científico publicado el 31 de julio de 2010

Upregulation of aspartoacylase seen in diabetes is due to advanced glycation end-products

artículo científico publicado en 2006

Withania somnifera root extract improves catecholamines and physiological abnormalities seen in a Parkinson's disease model mouse.

artículo científico publicado en 2009

Lista de obras de Sankar Surendran

Adeno-associated virus-mediated aspartoacylase gene transfer to the brain of knockout mouse for canavan disease

Altered expression of myocilin in the brain of a mouse model for phenylketonuria (PKU).

Altered expression of neuronal nitric oxide synthase in the duodenum longitudinal muscle-myenteric plexus of obesity induced diabetes mouse: implications on enteric neurodegeneration.

Ashwagandha leaf extract: a potential agent in treating oxidative damage and physiological abnormalities seen in a mouse model of Parkinson's disease.

Aspartoacylase Deficiency in the White Matter of Human Immunodeficiency Virus Encephalitis: Novel Mechanism in Axonal Damage ⬇️

Aspartoacylase gene knockout in the mouse: impact on reproduction

Aspartoacylase gene knockout results in severe vacuolation in the white matter and gray matter of the spinal cord in the mouse

Biopterin responsive phenylalanine hydroxylase deficiency

Canavan disease: a monogenic trait with complex genomic interaction.

Correction of kinetic and stability defects by tetrahydrobiopterin in phenylketonuria patients with certain phenylalanine hydroxylase mutations

DOOR syndrome: deficiency of E1 component of the 2-oxoglutarate dehydrogenase complex.

Defective N-acetylaspartate catabolism reduces brain acetate levels and myelin lipid synthesis in Canavan's disease.

Expression of calpastatin, minopontin, NIPSNAP1, rabaptin-5 and neuronatin in the phenylketonuria (PKU) mouse brain: possible role on cognitive defect seen in PKU.

Expression of glutamate transporter, GABRA6, serine proteinase inhibitor 2 and low levels of glutamate and GABA in the brain of knock-out mouse for Canavan disease

Fas (CD95) alters neuronal nitric oxide synthase expression to contribute in diabetic gastroparesis

Founder mutation R245H of Sanfilippo syndrome type A in the Cayman Islands

High level of orexin A observed in the phenylketonuria mouse brain is due to the abnormal expression of prepro-orexin.

High levels of orexin A in the brain of the mouse model for phenylketonuria: possible role of orexin A in hyperactivity seen in children with PKU.

Hyaluronidase increases the biodistribution of acid alpha-1,4 glucosidase in the muscle of Pompe disease mice: an approach to enhance the efficacy of enzyme replacement therapy

Malonyl CoA decarboxylase deficiency: C to T transition in intron 2 of the MCD gene.

Mental retardation and hypotonia seen in the knock out mouse for Canavan disease is not due to succinate semialdehyde dehydrogenase deficiency.

Mouse neural progenitor cells differentiate into oligodendrocytes in the brain of a knockout mouse model of Canavan disease

Mutations in the Regulatory Domain of Phenylalanine Hydroxylase and Response to Tetrahydrobiopterin

Parkinson's disease: oxidative stress and therapeutic approaches.

Possible role of fas antigen (CD 95) in human amniotic epithelial cell death: an in vitro study

Soluble factors from IL-1β-stimulated astrocytes activate NR1a/NR2B receptors: implications for HIV-1-induced neurodegeneration.

Trends in enzyme therapy for phenylketonuria.

Upregulation of N-acetylaspartic acid alters inflammation, transcription and contractile associated protein levels in the stomach and smooth muscle contractility.

Upregulation of N-acetylaspartic acid induces oxidative stress to contribute in disease pathophysiology.

Upregulation of N-acetylaspartic acid resulting nitric oxide toxicity induces aspartoacylase mutations and protein interaction to cause pathophysiology seen in Canavan disease ⬇️

Upregulation of aspartoacylase seen in diabetes is due to advanced glycation end-products

Withania somnifera root extract improves catecholamines and physiological abnormalities seen in a Parkinson's disease model mouse.